RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Genentech Inc.

A collection of news and information related to Genentech Inc. published by this site and its partners.

Top Genentech Inc. Articles see all

Displaying items 1-5
  • Asthma drug calms chronic hives, rashes

    Sufferers of chronic hives and rashes could benefit from a commonly-used asthma drug, Johns Hopkins researchers have found.
  • Google's health firm Calico announces massive investment in treatments for the elderly

    MOUNTAIN VIEW, Calif. In its first major step since its formation last year, Google's life-science spin-off on Wednesday announced a partnership with drug-giant AbbVie to build a "world-class research and development" facility in the Bay Area and spend up...

    Google's Calico, AbbVie forge deal against diseases of aging

    (Reuters) - U.S. drugmaker AbbVie Inc and Calico, a new company set up by Google Inc to cure diseases of aging, will each invest $250 million to help create Calico research facilities and collaborate on discovery and development of new medicines. AbbVie...

    Exclusive: U.S. approval of Merck cancer immunotherapy expected soon

    Exclusive: U.S. approval of Merck cancer immunotherapy expected soon
    U.S. regulators are likely to approve Merck & Co's highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline, according to three sources familiar with the situation. If approved by the...

    Roche to buy U.S. biotech firm InterMune for $8.3 billion

    Roche to buy U.S. biotech firm InterMune for $8.3 billion
    Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc. for $8.3 billion in cash, helping the world's leading maker of cancer drugs expand into the treatment of rare or incurable diseases. Roche's efforts to produce successful non-...